我院门诊口服降糖药应用情况分析  

Analysis on Usage of Oral Hypoglycemic Agents by Outpatient in the Hospital

作　　者：姜鹏[1] 鲁薇[1] 张少华[1] 

机构地区：[1]马鞍山市人民医院药事科,安徽马鞍山243000

出　　处：《中国药物评价》2014年第4期218-220,共3页Chinese Journal of Drug Evaluation

摘　　要：目的：分析我院2010～2012年门诊口服降糖药物的应用情况，为临床合理用药提供参考。方法：从HIS系统中调取2010～2012年中门诊各类口服降糖药物的使用数据，对其使用频率、日均费用等进行对比分析。结果：阿卡波糖销售金额连续3年排首位；二甲双胍的使用频率逐年上升，连续2年位居第一，且日平均费用最低；序号比大于1的药物为二甲双胍。结论：该院口服降糖药物的应用基本合理，二甲双胍使用频率高，符合安全、有效、经济的用药原则。Objective：To analyze the use of oral hypoglycemic agents by outpatient in the hospital during 2010-2012 , so as to pro-vide preference for clinical rational drug use.Methods：The information of various types of oral hypoglycemic by outpatient during 2010~2012 from the HIS system was obtained , the using frequency and cost per day were statistically analyzed and compared.Results：Acar-bose of sales amount for three consecutive years first row.Metformin of use frequency increased year by year , 2 years in first row, and the cost per day minimum.The serial number ratio greater than 1 is metformin.Conclusion：The use of oral hypoglycemic agent in the hospi-tal is reasonable , metformin of use frequency is high , conform to the principle of safe , effective and economic medication.

关 键 词：口服降糖药 限定日剂量 用药频度 

分 类 号：R95[医药卫生—药学]